FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105442647> ?p ?o ?g. }

• W2105442647 endingPage "A86" @default.
• W2105442647 startingPage "A86" @default.
• W2105442647 abstract "Schizophrenia and bipolar disorder (BD) are psychiatric disorders that are associated with a substantial clinical and economic burden. Hospitalization and in-patient care commonly account for a large proportion of medical costs in these illnesses. A secondary objective of the Italian Burden of Illness on Schizophrenia and BD (IBIS) study is to assess any differences in terms of cost of illness for patients with schizophrenia and BD switching from QTP-IR to QTP-XR. Multicenter, retrospective, observational, real world cohort study (NCT01392482). The data shown are interim results collected from administrative databases in 6 of 20 Italian Local Health Units included in the study. Data were collected between 1 January 2009 and 31 December 2010. Patients that switched from QTP-IR to QTP-XR were included for analysis. Data were collected 6 months before (IR period) and 6 months after (XR period) the switch. In total, 213 patients switched medication from QTP-IR to QTP-XR (86 with schizophrenia, 127 with BD). For patients with schizophrenia, disease-related costs per patient totaled €4123 during the IR period and €3832 during the XR period, indicating a decrease of 7%. Although hospitalization costs per patient remained similar after the switch (IR period: €1111, 26.9% of total costs; XR period: €998, 26.0% of total costs), care/nursing home costs decreased in the XR period (IR period: €1906, 46.2% of total costs; XR period: €1330, 34.7% of total costs). For patients with BD, disease-related costs per patient decreased by 23%, from €3877 during the IR period to €2,973 during the XR period. Hospitalization costs per patient fell substantially after the switch (IR period: €2659, 68.6% of total costs; XR period: €1,171, 39.4% of total costs). These interim results suggest that switching from QTP-IR to QTP-XR decreases direct health care costs and in-patient resource use." @default.
• W2105442647 created "2016-06-24" @default.
• W2105442647 creator A5000979181 @default.
• W2105442647 creator A5002902382 @default.
• W2105442647 creator A5030097532 @default.
• W2105442647 creator A5042358274 @default.
• W2105442647 creator A5053214629 @default.
• W2105442647 creator A5056735832 @default.
• W2105442647 creator A5088337467 @default.
• W2105442647 date "2012-06-01" @default.
• W2105442647 modified "2023-09-26" @default.
• W2105442647 title "PMH25 Cost and Use of Resources in Patients with Schizophrenia and Bipolar Disorder Switching from Immediate Release Quetiapine (QTP-IR) to Extended Release Quetiapine (QTP-XR) in Italy- the IBIS Study" @default.
• W2105442647 doi "https://doi.org/10.1016/j.jval.2012.03.470" @default.
• W2105442647 hasPublicationYear "2012" @default.
• W2105442647 type Work @default.
• W2105442647 sameAs 2105442647 @default.
• W2105442647 citedByCount "0" @default.
• W2105442647 crossrefType "journal-article" @default.
• W2105442647 hasAuthorship W2105442647A5000979181 @default.
• W2105442647 hasAuthorship W2105442647A5002902382 @default.
• W2105442647 hasAuthorship W2105442647A5030097532 @default.
• W2105442647 hasAuthorship W2105442647A5042358274 @default.
• W2105442647 hasAuthorship W2105442647A5053214629 @default.
• W2105442647 hasAuthorship W2105442647A5056735832 @default.
• W2105442647 hasAuthorship W2105442647A5088337467 @default.
• W2105442647 hasBestOaLocation W21054426471 @default.
• W2105442647 hasConcept C118552586 @default.
• W2105442647 hasConcept C121955636 @default.
• W2105442647 hasConcept C144133560 @default.
• W2105442647 hasConcept C2776174506 @default.
• W2105442647 hasConcept C2776412080 @default.
• W2105442647 hasConcept C2776921671 @default.
• W2105442647 hasConcept C2780494398 @default.
• W2105442647 hasConcept C2780634440 @default.
• W2105442647 hasConcept C2780733359 @default.
• W2105442647 hasConcept C2911140283 @default.
• W2105442647 hasConcept C6964187 @default.
• W2105442647 hasConcept C71924100 @default.
• W2105442647 hasConceptScore W2105442647C118552586 @default.
• W2105442647 hasConceptScore W2105442647C121955636 @default.
• W2105442647 hasConceptScore W2105442647C144133560 @default.
• W2105442647 hasConceptScore W2105442647C2776174506 @default.
• W2105442647 hasConceptScore W2105442647C2776412080 @default.
• W2105442647 hasConceptScore W2105442647C2776921671 @default.
• W2105442647 hasConceptScore W2105442647C2780494398 @default.
• W2105442647 hasConceptScore W2105442647C2780634440 @default.
• W2105442647 hasConceptScore W2105442647C2780733359 @default.
• W2105442647 hasConceptScore W2105442647C2911140283 @default.
• W2105442647 hasConceptScore W2105442647C6964187 @default.
• W2105442647 hasConceptScore W2105442647C71924100 @default.
• W2105442647 hasIssue "4" @default.
• W2105442647 hasLocation W21054426471 @default.
• W2105442647 hasOpenAccess W2105442647 @default.
• W2105442647 hasPrimaryLocation W21054426471 @default.
• W2105442647 hasRelatedWork W17013907 @default.
• W2105442647 hasRelatedWork W1987892448 @default.
• W2105442647 hasRelatedWork W2082440214 @default.
• W2105442647 hasRelatedWork W2124086610 @default.
• W2105442647 hasRelatedWork W2330688819 @default.
• W2105442647 hasRelatedWork W2330988487 @default.
• W2105442647 hasRelatedWork W2765622043 @default.
• W2105442647 hasRelatedWork W2768599656 @default.
• W2105442647 hasRelatedWork W4299421095 @default.
• W2105442647 hasRelatedWork W4313410386 @default.
• W2105442647 hasVolume "15" @default.
• W2105442647 isParatext "false" @default.
• W2105442647 isRetracted "false" @default.
• W2105442647 magId "2105442647" @default.
• W2105442647 workType "article" @default.